ARCH VENTURE MANAGEMENT, LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | VIR | 12.92M | $115.73M |
 | GOSS | 8.06M | $2.65M |
 | ERAS | 7.09M | $114.74M |
 | BEAM | 4.54M | $108.19M |
 | MAZE | 4.12M | $122.98M |
 | RAPP | 3.73M | $116.67M |
 | LYEL | 3.25M | $65.14M |
 | GENB | 1.94M | $24.31M |
 | QTTB | 320K | $2.06M |
 | TXG | 218K | $4.62M |
Vir Biotechnology, Inc.
VIR
Shares Held
12.92M
Value
$115.73M
Gossamer Bio, Inc.
GOSS
Shares Held
8.06M
Value
$2.65M
Erasca, Inc.
ERAS
Shares Held
7.09M
Value
$114.74M
Beam Therapeutics Inc.
BEAM
Shares Held
4.54M
Value
$108.19M
Maze Therapeutics, Inc.
MAZE
Shares Held
4.12M
Value
$122.98M
Rapport Therapeutics, Inc. Common Stock
RAPP
Shares Held
3.73M
Value
$116.67M
Lyell Immunopharma, Inc.
LYEL
Shares Held
3.25M
Value
$65.14M
Generate Biomedicines, Inc.
GENB
Shares Held
1.94M
Value
$24.31M
Q32 Bio Inc.
QTTB
Shares Held
320K
Value
$2.06M
10x Genomics, Inc.
TXG
Shares Held
218K
Value
$4.62M